Sarcoma  >>  DeltaRex-G (retroviral expression vectors bearing inhibitory genes)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DeltaRex-G (retroviral expression vectors bearing inhibitory genes) / GenVivo
NCT00572130: Phase II Study of Intravenous Rexin-G in Osteosarcoma

Completed
2
22
US
Rexin-G Dose 1, Rexin-G Dose 2
Epeius Biotechnologies
Osteosarcoma
07/10
06/11
NCT00505713: Safety and Efficacy Study Using Rexin-G for Sarcoma

Completed
1/2
36
US
Rexin-G
Epeius Biotechnologies
Sarcoma
07/10
06/11

Download Options